Production (Stage)
Predictmedix AI Inc.
PMED
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -45.75% | -55.76% | -58.18% | -49.35% | -19.57% |
| Depreciation & Amortization | -28.20% | -9.18% | -5.82% | -3.72% | -1.13% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.07% | -51.69% | -56.03% | -47.97% | -21.20% |
| Operating Income | 44.07% | 51.69% | 55.95% | 47.80% | 20.70% |
| Income Before Tax | 34.05% | 42.55% | 55.50% | 47.59% | 20.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.05% | 42.55% | 55.50% | 47.59% | 20.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.05% | 42.55% | 55.50% | 47.59% | 20.59% |
| EBIT | 44.07% | 51.69% | 55.95% | 47.80% | 20.70% |
| EBITDA | 47.52% | 55.53% | 56.09% | 49.63% | 27.03% |
| EPS Basic | 36.67% | 45.19% | 60.56% | 56.00% | 35.71% |
| Normalized Basic EPS | 48.21% | 55.38% | 61.80% | 56.38% | 36.36% |
| EPS Diluted | 36.67% | 45.19% | 60.56% | 56.00% | 35.71% |
| Normalized Diluted EPS | 48.21% | 55.38% | 61.80% | 56.38% | 36.36% |
| Average Basic Shares Outstanding | 6.21% | 5.18% | 10.68% | 16.99% | 22.50% |
| Average Diluted Shares Outstanding | 6.21% | 5.18% | 10.68% | 16.99% | 22.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |